Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Primary Glioblastoma × CNS × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 1731 Glioblastoma 1620 Glioma 1022 Central Nervous System Neoplasms 549 Astrocytoma 538 Neuroblastoma 503 Gliosarcoma 428 Oligodendroglioma 335 Neoplasms 286 Breast Neoplasms 254 Medulloblastoma 240 Carcinoma, Non-Small-Cell Lung 206 Recurrence 178 Sarcoma 168 Meningioma 164 Melanoma 164 Ependymoma 164 Neoplasm Metastasis 163 Lung Neoplasms 138 Lymphoma 122 Osteosarcoma 117 Meningeal Carcinomatosis 114 Neurofibromatosis 1 107 Wilms Tumor 103 Ovarian Neoplasms 98 Precursor Cell Lymphoblastic Leukemia-Lymphoma 96 Diffuse Intrinsic Pontine Glioma 96 Rhabdomyosarcoma 93 Lymphoma, Non-Hodgkin 92 Burkitt Lymphoma 83

Interventions

pembrolizumab 1 Temozolomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07347210 2026-01-16

MATVAC-1

Centre Hospitalier Universitaire de Besancon

Phase 2 Not yet recruiting

Primary Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡